SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Nabi (NABI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeff Dutter who wrote (1)1/25/1997 7:13:00 PM
From: The BayWatcher   of 354
 
Jeff, the recent interest in NABI wasÿtheir
announcement last week that there were no safety
concerns for their HIV product testing and that, as
a result, further Phase III testing will continue.
Today, at an HIV conference, NABI's CEO was
scheduled to address the conference attendees about
this new drug. On Friday, after the conference
call with NABI's CEO, the DLJ brokerage firm
reiterated a BUY on NABI and kept it on its
preferred stock list with a traget of 21. Earnings
come out during the week of 2/17 and it seem
certain the company will meet or exceed estimates
given that their supply of plasma is sold out for
the entire 1997 year. We're looking really good
with this stock.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext